We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+14.51%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$933M
AUM Growth
+$188M
(+25%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
12.64%
Top 10 Holdings %
Top 10 Hldgs %
79.57%
Holding
39
New
10
Increased
6
Reduced
7
Closed
7
Top Buys
| 1 |
Arcus Biosciences
RCUS
|
+$37.3M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$24.2M |
| 3 |
Wave Life Sciences
WVE
|
+$22M |
| 4 |
Protagonist Therapeutics
PTGX
|
+$20.4M |
| 5 |
UroGen Pharma
URGN
|
+$20.2M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$32.8M |
| 2 |
Ascendis Pharma A/S
ASND
|
+$16M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$10.3M |
| 4 |
ONC
BeOne Medicines Ltd
ONC
|
+$8.18M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
+$5.62M |
Sector Composition
| 1 | Healthcare | 93.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Assembly Biosciences
ASMB
$532M
| $145M | 15.5% |
245,264
| – | – |
|
|
2
Ascendis Pharma A/S
ASND
$17.5B
| $119M | 12.77% |
1,822,575
-285,025
| -14% | -$16M |
|
|
KYNB
3
Kyntra Bio
KYNB
$29.8M
| $92.5M | 9.91% |
80,097
-1,812
| -2% | -$2.39M |
|
4
Ironwood Pharmaceuticals
IRWD
$658M
| $90.8M | 9.73% |
7,027,386
| – | – |
|
5
Kura Oncology
KURA
$1B
| $70.6M | 7.57% |
3,766,852
| – | – |
|
|
6
Wave Life Sciences
WVE
$1.14B
| $58.5M | 6.27% |
1,459,072
+522,909
| +56% | +$22M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $49.8M | 5.33% |
3,049,312
+166,600
| +6% | +$2.67M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $45.5M | 4.88% |
4,764,447
-72,100
| -1% | -$777K |
|
9
MacroGenics
MGNX
$271M
| $36.5M | 3.91% |
1,450,606
+309,812
| +27% | +$7.53M |
|
|
10
Arcus Biosciences
RCUS
$3.51B
| $34.5M | 3.7% |
+2,236,387
| New | +$37.3M |
|
|
APLS
11
DELISTED
Apellis Pharmaceuticals
APLS
| $23.4M | 2.5% |
1,056,348
-88,210
| -8% | -$1.73M |
|
|
FPRX
12
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $21.3M | 2.28% |
+1,240,470
| New | +$24.2M |
|
|
13
UroGen Pharma
URGN
$1.95B
| $20M | 2.14% |
+402,300
| New | +$20.2M |
|
|
IMDZ
14
DELISTED
Immune Design Corp.
IMDZ
| $14.4M | 1.55% |
4,437,600
+875,000
| +25% | +$3.1M |
|
15
Agios Pharmaceuticals
AGIO
$2.38B
| $14.1M | 1.52% |
+172,952
| New | +$13.4M |
|
16
Akebia Therapeutics
AKBA
$368M
| $13.6M | 1.46% |
+1,425,000
| New | +$19.9M |
|
|
ACHN
17
DELISTED
Achillion Pharmaceuticals
ACHN
| $13.6M | 1.45% |
3,668,307
+1,827,582
| +99% | +$5.98M |
|
|
DOVA
18
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $11.7M | 1.25% |
+429,729
| New | +$12.9M |
|
|
ATYR
19
aTyr Pharma
ATYR
$53.5M
| $10.6M | 1.13% |
279,855
| – | – |
|
|
DBVT
20
DBV Technologies
DBVT
$929M
| $10.4M | 1.11% |
+45,000
| New | +$10.6M |
|
|
21
Protagonist Therapeutics
PTGX
$8.82B
| $9.31M | 1% |
+1,083,567
| New | +$20.4M |
|
|
SYBX
22
DELISTED
Synlogic
SYBX
| $6.57M | 0.7% |
+46,667
| New | +$7.23M |
|
23
Denali Therapeutics
DNLI
$3.63B
| $6.4M | 0.69% |
325,000
+125,000
| +63% | +$2.57M |
|
|
24
Rhythm Pharmaceuticals
RYTM
$7.49B
| $6.34M | 0.68% |
318,564
-211,597
| -40% | -$5.62M |
|
25
Corvus Pharmaceuticals
CRVS
$1.26B
| $5.42M | 0.58% |
469,700
-118,732
| -20% | -$1.12M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM